As global climate talks at COP30 shift from setting lofty targets to transforming the systems that will get us there, ...

MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced its financial results for the three and nine-month period ended September 30, 2025.

Q3 2025 Earnings Call November 12, 2025 8:00 AM ESTCompany ParticipantsCaspar Coppetti - Co-Founder & Executive ...

NEW REVOLVING CREDIT FACILITY (“RCF”) PROVIDES INCREASED LIQUIDITY New RCF will allow Discovery to borrow up to $250 million, with an accordion feature for an additional $100 million. The agreement is ...

Topline data for RAPIDe-3, a pivotal Phase 3 study of deucrictibant immediate-release capsule for the on-demand treatment of HAE attacks, ...

The following selected financial data are derived from our unaudited condensed interim consolidated financial statements and related notes thereto (the “Interim Financial Statements”) for the three ...

A word from the CEO"We are pleased to report continued progress for our UBC bladder cancer test during the past quarter. UBC tests continue to show steady growth, reflecting the strength of our produc ...

Discusses Acquisition of Edgewell Feminine Care Brands and Expansion in North America November 13, 2025 3:00 AM ...

Detailed price information for Medexus Pharmaceuticals Inc (MDP-T) from The Globe and Mail including charting and trades.

Topline data for RAPIDe-3, a pivotal Phase 3 study of deucrictibant immediate-release capsule for the on-demand treatment of HAE attacks, expected in 4Q2025Enrollment in CHAPTER-3, a pivotal Phase 3 ...

Q1 2026 Earnings Call Transcript November 10, 2025 Sangoma Technologies Corporation beats earnings expectations. Reported EPS is $0.01, expectations were $-0.04. Operator: Thank you for standing by.

AIR Limited ("AIR" or the "Company"), the global leader in hookah and pioneer in advanced inhalation technologies, and Cantor Equity Partners III, Inc. (Nasdaq: CAEP) ("CAEP"), a special purpose ...